








































ACID-BASE AND ELECTROLYTE TEACHING CASE
Acute Tubular Dysfunction With Fanconi Syndrome: A New
Manifestation of Mitochondrial Cytopathies
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sitochondrial diseases are a heterogeneous
group of energy metabolism disorders
hat can affect almost any organ.1 Kidney disease
s well-known in patients with mitochondrial
isorders, most commonly manifesting as proxi-
al tubulopathy with chronic tubular acidosis,
ypically a minor feature in pediatric patients
ith severe involvement of brain, liver, heart, or
ther organs.2-5 Other renal presentations in-
lude chronic tubulointerstitial nephropathy,6,7
rogressive glomerular diseases,8,9 and nephrotic
yndrome.10 Acute, severe, and fluctuant tubular




A girl born to first-cousin Turkish parents was admitted at
ge 2 weeks for failure to thrive, tachypnea, and fever. Blood
hemistry results were as follows: pH, 7.07; PCO2, 57.6 mm
g; bicarbonate, 16 mEq/L (mmol/L); anion gap, 16 mEq/L
mmol/L); lactate, 74 mg/dL (8.27 mmol/L; normal, 20
g/dL); and lactate-pyruvate molar ratio, 41.9 (normal,
17). She received antibiotics for suspected sepsis. Acid-
ase status thereafter normalized. Plasma phosphorus level
as 6.9 mg/dL (2.3 mmol/L), and tubular reabsorption of
hosphate was 91%. The patient was readmitted at 4 months
or fever. Blood chemistry showed pH of 7.19; PCO2 of 43.2
m Hg; bicarbonate of 15.3 mEq/L (mmol/L); anion gap of
0.1 mEq/L (mmol/L); and lactate level of 17.7 mg/dL (1.97
mol/L). Urinary pH was 6.0 and glycosuria was absent.
enal tubular acidosis was suspected and bicarbonate was
dministered. Psychomotor delay and neurosensory deaf-
ess were documented, and she required nasogastric tube
eeding.
Because of multisystemic involvement, a mitochondrial
isease was suspected, and at 7 months, the patient was
lectively admitted for investigations. Blood analyses showed
he following values: pH, 7.33; PCO2, 39 mm Hg; bicarbon-
te, 22.0 mEq/L (mmol/L); and anion gap, 12.0 mEq/L
mmol/L). Urinary pH was 8.0, and there was generalized
minoaciduria without glycosuria (Fig 1A). Plasma phospho-
us level was 3.3 mg/dL (1.10 mmol/L; normal, 1.45 to 2.1
mol/L), and tubular reabsorption of phosphate was 72%.
uscle biopsy results were normal, but liver showed marked
itochondrial proliferation and ultrastructural anomalies.
merican Journal of Kidney Diseases, Vol 51, No 4 (April), 2008: pAt 1 year, the patient was readmitted for fever. Blood
nalysis results were as follows: pH, 7.35; PCO2, 26.2 mm
g; bicarbonate, 14.4 mEq/L (mmol/L); anion gap, 15.6
Eq/L (mmol/L); and lactate, 40 mg/dL (4.44 mmol/L).
rinary pH was 6.0, and glycosuria showed glucose of 252
g/dL (14 mmol/L). Bicarbonate administration was tran-
iently doubled. Two weeks later, electrolyte imbalances
esolved, and she returned to her previous level of bicarbon-
te supplementation. At this age, renal investigations repeat-
dly showed generalized aminoaciduria, normoglycemic gly-
osuria (glucose, 180 mg/dL [10 mmol/L]), proteinuria
protein, 0.12 g/dL [1.19 g/L]), hypophosphatemia (phos-
hate, 1.5 mg/dL [0.5 mmol/L]), low tubular reabsorption of
hosphate (52%), hypercalciuria (urinary calcium-creatinine
atio, 5.96), and mild nephrocalcinosis. Blood pH was 7.31,
lasma bicarbonate level was 19 mEq/L (mmol/L), and
rinary pH was 7.0. Plasma creatinine level was 0.2 mg/dL
18 mol/L), and glomerular filtration rate measured by
sing creatinine clearance was 110 mL/min/1.73 m2 (1.83
L/s/1.73 m2). Phosphorus was administered.
At 15 months, another major metabolic crisis occurred.
nitial laboratory values were pH, 7.11; PCO2, 31 mm Hg;
icarbonate, 11 mEq/L (mmol/L); anion gap, 14 mEq/L
mmol/L); lactate, 62 mg/dL (6.88 mmol/L); and urinary pH,
.0. Bicarbonate requirements increased 10-fold (to 22 mEq
mmol]/kg/d intravenously), and phosphorus, to 95 mg/kg/d
Fig 2A). Glycosuria exceeded 1 g/L (55 mmol/L). Unex-
ectedly, tubular losses improved and all electrolyte supple-
ents were stopped within 5 weeks. For 5 additional weeks,
ean plasma bicarbonate and phosphorus concentrations
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Debray et al692ere 24.8 1.9 (SD) mEq/L (mmol/L) and 5.1 0.3 mg/dL
1.7  0.1 mmol/L), respectively. Glycosuria disappeared.
ypophosphatemia and acidosis recurred thereafter, with
ntermittent glycosuria (glucose, 0 to 100 mg/dL [0 to 5
mol/L]), and supplementations were reintroduced (Fig 1A).phe patient had severe encephalopathy and developed hyp-
arrhythmia and sideroblastic anemia requiring multiple
ransfusions.
At 21 months, the patient was admitted for vomiting and
ever and rapidly developed profound metabolic acidosis
ncontrolled by bicarbonate infusion. Lactic acidemia in-
reased to 315 mg/dL (35 mmol/L), and she died of multiple
rgan failure. Autopsy included muscle and kidney biopsies
erformed 1 hour postmortem. Muscle was normal, but
roximal tubular cells showed massive mitochondrial prolif-
ration (Fig 3A).
Patient2
This girl born to unrelated French-Canadian parents at 35
eeks of gestation was admitted at age 2 months for irritabil-
ty and poor weight gain. Blood analysis showed the follow-
ng values: pH, 7.42; PCO2, 26 mm Hg; bicarbonate, 17.0
Eq/L (mmol/L); anion gap, 11 mEq/L (mmol/L); lactate,
0 mg/dL (7.73 mmol/L), and lactate-pyruvate ratio, 40.6.
lycosuria and aminoaciduria were absent. Nasogastric tube
eeding was introduced and bicarbonate was administered
Fig 1B). At age 9 months, serum creatinine level was 0.73
g/dL (65 mol/L), and isotopic glomerular filtration rate
as 42 mL/min/1.73 m2 (0.70 mL/s/1.73 m2). Urinalysis
howed normoglycemic glycosuria (glucose, 100 mg/dL
5.5 mmol/L]), proteinuria (protein, 0.63 g/L), pH of 7, and
eneralized aminoaciduria. Plasma phosphorus concentra-
ion was normal (4.5 mg/dL [1.50 mmol/L]), and plasma
icarbonate level was 20 mEq/L (mmol/L). Renal biopsy at
months, normal by means of light microscopy, showed
itochondrial proliferation and abnormalities by electron
icroscopy in proximal tubular cells (Fig 3B). During the
ollowing months, bicarbonate supplementation was in-
reased to 7 mEq (mmol)/kg/d, but growth remained im-
aired. She walked unaided at 16 months and language
evelopment was normal.
At 30 months, the patient presented with a severe acidotic
risis requiring continuous intravenous bicarbonate infusion
up to 33 mEq [mmol]/kg/24 h) for nearly 1 month (Fig 2B).
t admission, she was polypneic and mildly dehydrated
weight loss 3%). Laboratory values were as follows: pH,
.07; PCO2, 26.9 mm Hg, bicarbonate, 3.3 mEq/L (mmol/L);
actate 195 mg/dL (21.7 mmol/L); anion gap, 23.7 mEq/L
mmol/L); and glucose, 150 mg/dL (8.3 mmol/L). Urinalysis
howed pH 5.0, glycosuria with glucose of 252 mg/dL (14
mol/L), and proteinuria with protein of 0.10 g/dL (1 g/L).
here were no neurological signs, and after an initial period
f hydration and bicarbonate infusion, she appeared clini-
™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
Figure 1. Lifelong course of patients (A) 1 and (B) 2.
oxes represent mean for bicarbonate (upper right-side
-axis) and elemental phosphorus (lower right-side y-axis)
dministrations, mean plasma bicarbonate (closed circle;
pper left-side y-axis ), mean anion gap (open circle; upper
eft-side y-axis), and mean plasma phosphorus (closed
iamond; lower left-side y-axis). Error bars are SD. Abbre-
iations: AA, aminoaciduria; creat, plasma creatinine. To
onvert creatinine in mg/dL to mol/L, multiply by 88.4;





















Atypical Tubulopathy in Mitochondrial Disease 693ally well, energetic, and in no distress. Bicarbonate admin-
stration was progressively decreased over 4 weeks to 6 mEq
mmol)/kg/d orally. She had a milder acidotic episode at age
years, but none thereafter. Chronic renal failure has progres-
ively developed (Fig 1B). In the last 6 months, plasma
hosphorus level decreased, with tubular reabsorption of
hosphate of 50% and radiological evidence of early rickets.
t 11 years, renal evaluation shows proteinuria with protein
™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
Figure 2. Chronology of biological parameters and
lectrolyte administration during acidotic episodes of pa-
ients (A) 1 and (B) 2. Grey boxes show supplementation
evels for bicarbonate (upper right-side y-axis) and phos-
horus (lower right-side y-axis). Shown are plasma bicar-
onate (closed circle; upper left-side y-axis), anion gap
open circle; upper left-side y-axis), and plasma phospho-
Figure 3. Electron micrographs show widespread pro-
iferation of mitochondria with bizarre shape and hypertro-
hic cristae occupying most of the volume of proximal
ubular cells. (A) Patient 1 (original magnification 3,000);
B) patient 2 (original magnification2,800).us (closed diamond; lower left-side y-axis). To convert






























































































Debray et al694f 0.15 g/dL (1.48 g/L), massive aminoaciduria and glycos-
ria (glucose  1 g/L), plasma creatinine level of 2.34
g/dL (207 mol/L), and creatinine clearance of 29.2 mL/
in/1.73 m2 (0.03 mL/s/1.73 m2). She receives phosphorus
nd 1,25-hydoxyvitamin D3. Of note, development and
eurological examination findings are normal.
dditional Investigations
Respiratory chain enzyme activities were measured in
broblasts and liver as reported.11,12 Blue native gel studies
ere performed in fibroblast and liver, as described.13 Spec-
rophotometric assays showed complex IV deficiency in the
iver of patient 1 (0.2 moles of reduced cytochrome c per
ram of wet weight tissue per minute; controls, 0.6 to 2.4).
lue native gel studies confirmed decreased levels of com-
lex IV in the liver of patient 1 and showed deficiency of
omplex I in fibroblasts of patient 2 (not shown).
linical Follow-up
Metabolic parameters and tubular function were assessed
rom the patients’ medical charts. The clinical course was
ivided into periods during which parameters of tubular
unction remained constant, shown in Fig 1. Major changes
n treatment, such as initiation or cessation of electrolyte
upplementation, were used to define new periods. Acute
cidotic episodes are presented chronologically (Fig 2).
DISCUSSION
Both patients fulfilled the diagnostic criteria of
anconi syndrome: aminoaciduria, normoglyce-
ic glycosuria, chronic tubular acidosis, and
mpaired renal phosphate reabsorption. In stable
eriods, when the patients were acidotic, urinary
H was appropriate for the level of acidosis,
ndicating preserved distal tubular acidifying ca-
acity. Conversely, in other instances, alkaline
rine was observed with normal plasma bicarbon-
te levels, suggesting a proximal origin of tubu-
ar acidosis. In addition to chronic tubulopathy,
oth experienced major acidotic crises requiring
assive bicarbonate administration (up to 22 and
3 mEq/kg/d). Without consideration of renal
unction, such episodes might falsely be attrib-
ted solely to hyperlactatemia. Although lactic
cid levels increased during episodes and contrib-
ted to the metabolic acidosis, anion gaps re-
ained normal or only modestly increased, indi-
ating that in the absence of digestive losses,
cidosis most probably was related to renal tubu-
ar dysfunction. Taken together with other signs
f proximal tubulopathy, the huge amount of
icarbonate required to maintain acid-base
quilibrium and observation of alkaline urine
t admission of crisis in patient 1 suggest that mcidotic crises were caused by renal bicarbonate
osses. In patients with mitochondrial diseases,
ubulopathy is often considered a biological
arker of little clinical significance, but this
eport shows that acute tubular failure can be life
hreatening.
In patients with Fanconi syndrome, tubular
osses generally are considered fairly constant.14
n addition to acidotic crises, patient 1 had tran-
ient phosphaturia and glycosuria that resolved
n parallel with the tubular acidosis. Patient 2
resented with very late-onset hypophosphatemic
ickets, unusual in patients with Fanconi syn-
rome and particularly surprising regarding her
hronic renal failure. Mitochondrial diseases
hould be considered in patients with atypical
anconi syndromes and unexplained multiple
ubular dysfunctions.
The reported spectrum of renal disease in
atients with mitochondrial diseases is listed in
able 1, with usual age at presentation, occur-
ence of extrarenal symptoms, and biochemical
r molecular findings. End-stage renal failure is
are in patients with mitochondrial diseases. In
9 patients with mitochondrial disease and tubu-
opathy, only 2 had moderate renal failure.2 In
nother prospective study, none of 35 patients
ad serum creatinine levels greater than 0.8
g/dL (71 mol/L).5 Chronic renal failure
as described in a patient with mitochondrial
iseases and tubulointerstitial nephritis without
ubulopathy.7 Mitochondrial DNA mutations can
ause segmental glomerulosclerosis,8 leading to
nd-stage renal failure.9 In these cases, renal
nsufficiency manifested later than in our patient
, and without tubulopathy. The kidney biopsy of
atient 2 was performed at age 9 months, and her
urrent glomerular histological state is unknown.
atient 2 shows that mitochondrial diseases can
resent as a primary renal disease without neuro-
ogical, hepatic, or cardiac involvement. She also
hows that chronic renal failure, rare in patients
ith mitochondrial diseases, can become the
ajor problem of some patients.
The pathophysiological characteristics of acute
ubular dysfunction are unclear, but several obser-
ations may be pertinent. Proximal tubules have
high metabolic rate, generating more than 95%
f their adenosine triphosphate by means of
xidative metabolism.19 Recent in vitro experi-








































Atypical Tubulopathy in Mitochondrial Disease 695s related to inhibition of mitochondrial respira-
ion, producing adenosine triphosphate depletion
nd secondary tubular damages.20 Functional
oupling between ion transport and aerobic respi-
ation was demonstrated in vitro.21 Moreover,
ven in normal proximal tubule cells, physiolog-
cal energy demand is close to the capacity for
denosine triphosphate generation, shown by the
apid decrease in adenosine triphosphate level
fter stimulation of epithelial sodium transport.22
his constant dependence of proximal tubular
ells on high levels of energy supply resembles
hat of the central nervous system. Acute neuro-
ogical crises, termed “metabolic stroke,” are
ell-known in patients with mitochondrial dis-
ases and may be related to imbalance between
nergy requirement and production, leading to
ell death. Of note, metabolic strokes in patients
ith mitochondrial diseases occur after such
tresses as minor infections, during which meta-
olic demands are presumably increased, compro-
ising energy homeostasis in tissues with im-
Table 1. Renal Manifestat





I, C Neurological d
multiviscera
I Neurological a






















NN, I Progressive ne
disease, car
Abbreviations: Adol, adolescence; C, childhood; I, infan
troke like episodes; mtDNA, mitochondrial DNA mutation;aired energy production capacity. Perhaps the tpisodes of acute tubular dysfunction in our
atients fall within a similar framework.
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